The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
Overview
The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, has completed its acquisition of the New York Stem Cell Foundation (NYSCF), a pioneering nonprofit dedicated to advancing cures through stem cell research.
In This Article
Reports on the new integrated platform that will transform early-stage research, equipping scientists worldwide to uncover disease mechanisms earlier and advance progress toward therapies for Alzheimer’s, cancer, diabetes, Parkinson’s, rare diseases and more
